Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Yves LE Roux

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Frontiers in Medicine|September 16, 2017
Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor ScintigraphyPhilippe Thuillier, David Bourhis, Philippe Robin, et al.
Nuclear Medicine Communications|June 30, 2010
Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanomaSolene Querellou, Nathalie Keromnes, Ronan Abgral, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2013
V/Q SPECT interpretation for pulmonary embolism diagnosis: which criteria to use?Pierre-Yves Le Roux, Philippe Robin, Aurélien Delluc, et al.
EJNMMI Research|February 14, 2018
A new SPECT/CT reconstruction algorithm: reliability and accuracy in clinical routine for non-oncologic bone diseasesOlivier Delcroix, Philippe Robin, Maelenn Gouillou, et al.
Plos One|June 2, 2017
Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolismPhilippe Robin, Pierre-Yves Le Roux, Karine Lacut, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinomaRonan Abgral, Pierre-Yves Le Roux, Nathalie Keromnes, et al.
Thrombosis Research|October 1, 2018
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systemsPhilippe Robin, Srishti Kumar, Pierre-Yves Salaun, et al.
Frontiers in Medicine|November 17, 2022
Quantification of the pulmonary vascular obstruction index on ventilation/perfusion lung scintigraphy: Comparison of a segmental visual scoring to the Meyer scoreRomain Le Pennec, Cécile Tromeur, Charles Orione, et al.
Nuclear Medicine Communications|February 12, 2019
Time trend analysis of pulmonary embolism diagnosis with single-photon emission computed tomography ventilation/perfusion imagingBlandine Truffault, Philippe Robin, Cecile Tromeur, et al.
Nuclear Medicine Communications|June 8, 2015
Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosisPierre-Yves Le Roux, Philippe Robin, Aurélien Delluc, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Medicine|September 16, 2017
Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor ScintigraphyPhilippe Thuillier, David Bourhis, Philippe Robin, et al.
Nuclear Medicine Communications|June 30, 2010
Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanomaSolene Querellou, Nathalie Keromnes, Ronan Abgral, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2013
V/Q SPECT interpretation for pulmonary embolism diagnosis: which criteria to use?Pierre-Yves Le Roux, Philippe Robin, Aurélien Delluc, et al.
EJNMMI Research|February 14, 2018
A new SPECT/CT reconstruction algorithm: reliability and accuracy in clinical routine for non-oncologic bone diseasesOlivier Delcroix, Philippe Robin, Maelenn Gouillou, et al.
Plos One|June 2, 2017
Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolismPhilippe Robin, Pierre-Yves Le Roux, Karine Lacut, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinomaRonan Abgral, Pierre-Yves Le Roux, Nathalie Keromnes, et al.
Thrombosis Research|October 1, 2018
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systemsPhilippe Robin, Srishti Kumar, Pierre-Yves Salaun, et al.
Frontiers in Medicine|November 17, 2022
Quantification of the pulmonary vascular obstruction index on ventilation/perfusion lung scintigraphy: Comparison of a segmental visual scoring to the Meyer scoreRomain Le Pennec, Cécile Tromeur, Charles Orione, et al.
Nuclear Medicine Communications|February 12, 2019
Time trend analysis of pulmonary embolism diagnosis with single-photon emission computed tomography ventilation/perfusion imagingBlandine Truffault, Philippe Robin, Cecile Tromeur, et al.
Nuclear Medicine Communications|June 8, 2015
Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosisPierre-Yves Le Roux, Philippe Robin, Aurélien Delluc, et al.
Pageof 11